tradingkey.logo
tradingkey.logo
Search

Apyx Medical Corp

APYX
Add to Watchlist
4.300USD
+0.460+11.98%
Market hours ETQuotes delayed by 15 min
180.03MMarket Cap
LossP/E TTM

Earnings Forecast

Currency: USD Updated: 2026-07-29
Previous score
8.40
Change
0
The current earnings forecast score of Apyx Medical Corp is 8.40, ranking 35 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 5.00, with a high of 8.00 and a low of 4.00.

Analyst Rating

Based on 5 analysts
Buy
Current Rating
6.600
Target Price
+69.67%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Apyx Medical Corp
APYX
5
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
31
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
31
1
2
3
...
22

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

FAQs

What is Apyx Medical Corp's expected revenue for the next quarter?

Apyx Medical Corp's expected revenue is 13.18M.

What is Apyx Medical Corp's price target?

Analysts forecast that Apyx Medical Corp's price target is USD 5.00, with the highest forecast at USD 8.00 and the lowest forecast at USD 4.00.

How have Apyx Medical CorpAPYX's recent earnings per share performed?

The market expectation was USD -0.05, while Apyx Medical CorpAPYX's earnings per share (EPS) for the previous quarter was USD -0.03. EPS for the next quarter is expected at USD -0.08.

What is the analyst rating for Apyx Medical Corp?

Based on the ratings of Apyx Medical Corp's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.